Facilitated Subcutaneous Immunoglobulin Treatment in Patients with Immunodeficiencies: the FIGARO Study

被引：0

作者：

Michael Borte

Leif G. Hanitsch

Nizar Mahlaoui

Maria Fasshauer

Dörte Huscher

Matthaios Speletas

Maria Dimou

Marta Kamieniak

Corinna Hermann

David Pittrow

Cinzia Milito

机构：

[1] Hospital for Children and Adolescents, IDCL (ImmunoDeficiency Center Leipzig)

[2] St. Georg Hospital,Institute of Medical Immunology

[3] Academic Teaching Hospital of the University of Leipzig,Pediatric Immunology

[4] Charité Universitätsmedizin Berlin,Hematology and Rheumatology Unit and French National Reference Center for Primary Immune Deficiencies (CEREDIH)

[5] Necker Children’s University Hospital,Institute of Biometry and Clinical Epidemiology, Berlin Institute of Health

[6] Assistance Publique-Hôpitaux de Paris (AP-HP),Faculty of Medicine, Department of Immunology and Histocompatibility, Faculty of Medicine, School of Health Sciences

[7] Charité Universitätsmedizin Berlin,First Department of Propaedeutic Internal Medicine, General Hospital “LAIKO”

[8] University of Thessaly,Institute for Clinical Pharmacology, Medical Faculty

[9] National & Kapodistrian University of Athens Medical School,Innovation Center Real World Evidence

[10] Takeda Development Center Americas,Department of Molecular Medicine

[11] Inc,undefined

[12] Baxalta Innovations GmbH,undefined

[13] a Takeda Company,undefined

[14] Technical University of Dresden,undefined

[15] GWT-TUD GmbH,undefined

[16] Sapienza University of Rome,undefined

来源：

Journal of Clinical Immunology | 2023年 / 43卷

关键词：

Facilitated subcutaneous immunoglobulin; Immunoglobulin replacement therapy; Primary immunodeficiency disease; Secondary immunodeficiency disease; Utilization pattern;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1259 / 1271

页数：12

共 50 条

[1] Facilitated Subcutaneous Immunoglobulin Treatment in Patients with Immunodeficiencies: the FIGARO Study
Borte, Michael
Hanitsch, Leif G. G.
Mahlaoui, Nizar
Fasshauer, Maria
Huscher, Dorte
Speletas, Matthaios
Dimou, Maria
Kamieniak, Marta
Hermann, Corinna
Pittrow, David
Milito, Cinzia
JOURNAL OF CLINICAL IMMUNOLOGY, 2023, 43 (06) : 1259 - 1271
[2] Insights into Facilitated Subcutaneous Immunoglobulin Use in Patients with Secondary Immunodeficiency Diseases: A FIGARO Subgroup Analysis
Dimou, Maria
Speletas, Matthaios
Milito, Cinzia
Pyzik, Aleksandra
Huscher, Doerte
Kamieniak, Marta
Pittrow, David
Borte, Michael
CANCERS, 2023, 15 (18)
[3] Population pharmacokinetics of immunoglobulin G after intravenous, subcutaneous, or hyaluronidase-facilitated subcutaneous administration in immunoglobulin-naive patients with primary immunodeficiencies
Li, Zhaoyang
Follman, Kristin
Freshwater, Ed
Engler, Frank
Yel, Leman
INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 128
[4] Facilitated Subcutaneous Immunoglobulin Treatment Increases the Quality of Life and Decreases the Number of Infections and Hospitalizations in Children with Primary Immunodeficiencies
Erbas Acici, Nida
Topyildiz, Ezgi
Ayguen, Ayse
Geyik, Mehmet
Edeer Karaca, Neslihan
Aksu, Guzide
Kutukculer, Necil
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2024, 185 (04) : 382 - 391
[5] Recombinant human hyaluronidase facilitated subcutaneous immunoglobulin treatment in pediatric patients with primary immunodeficiencies: long-term efficacy, safety and tolerability
Wasserman, Richard L.
Melamed, Isaac
Kobrynski, Lisa
Puck, Jennifer
Gupta, Sudhir
Doralt, Jennifer
Sharkhawy, Marlies
Engl, Werner
Leibl, Heinz
Gelmont, David
Yel, Leman
IMMUNOTHERAPY, 2016, 8 (10) : 1175 - 1185
[6] Real-world use of facilitated subcutaneous immunoglobulin in patients with secondary immunodeficiency diseases (SID): interim results from the FIGARO study
Dimou, M.
Huscher, D.
Hermann, C.
Pittrow, D.
Speletas, M.
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 184 - 184
[7] Facilitated subcutaneous immunoglobulin treatment patterns in pediatric patients with primary immunodeficiency diseases
Mach-Tomalska, Monika
Pituch-Noworolska, Anna
Bien, Ewa
Malanowska, Magdalena
Machura, Edyta
Pukas-Bochenek, Anna
Chrobak, Ewelina
Pac, Malgorzata
Pietrucha, Barbara
Drygala, Szymon
Kamieniak, Marta
Kasprzak, Jakub
Heropolitanska-Pliszka, Edyta
IMMUNOTHERAPY, 2024, 16 (06) : 391 - 403
[8] Subcutaneous immunoglobulin replacement in primary immunodeficiencies
Berger, M
CLINICAL IMMUNOLOGY, 2004, 112 (01) : 1 - 7
[9] Facilitated immunoglobulin administration registry and outcomes study (FIGARO): first results
Huscher, D.
Borte, M.
Hanitsch, L. G.
Mahlaoui, N.
Quinti, I.
Speletas, M.
Panagiotidis, P.
Pittrow, D.
ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 117 - 118
[10] Subcutaneous immunoglobulin replacement in patients with primary immunodeficiencies (PID) - Portuguese experience
Faria, E.
Lopes-Silva, S.
Marques, L.
Guedes, M.
Goncalo-Marques, J.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 154 : 103 - 104

← 1 2 3 4 5 →